Xixone S 1000mg/500mg Injection
Marketer
Xieon Life Sciences Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Xixone S 1000mg/500mg Injection
Combix 1000mg/500mg Injection, a dual-action antibiotic, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curtailing infection spread. Administration must be solely under a doctor's guidance; adhere strictly to the prescribed dosage schedule. Complete the entire treatment course, regardless of symptom improvement; premature cessation compromises efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms immediately. Allergic reactions (rash, pruritus, edema, dyspnea) necessitate urgent medical attention. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential synergistic drowsiness. While typically non-impairing, driving is discouraged if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and ample hydration are crucial for optimal recovery. Your physician may order tests to monitor therapeutic response.
Primary Ingredients of Xixone S 1000mg/500mg Injection
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Xixone S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Xixone S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Xixone S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Xixone S 1000mg/500mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Xixone S 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Xixone S 1000mg/500mg Injection, offer a powerful antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to survive. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant use of alcohol and Xixone S 1000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Xixone S (1000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Xixone S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be suspended throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Xixone S 1000mg/500mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Xixone S 1000mg/500mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Xixone S 1000mg/500mg Injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Altering the dose of Xixone S 1000mg/500mg Injection is unnecessary for patients experiencing mild to moderate liver dysfunction.
What if you forget to take Xixone S 1000mg/500mg Injection :
Should you inadvertently skip a dose of Xixone S 1000mg/500mg Injection, seek medical advice.
Facts to Know About Xixone S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently